RS49955B - Stabilne kompozicije koje sadrže levosimendan i alginsku kiselinu - Google Patents

Stabilne kompozicije koje sadrže levosimendan i alginsku kiselinu

Info

Publication number
RS49955B
RS49955B YUP-640/00A YU64000A RS49955B RS 49955 B RS49955 B RS 49955B YU 64000 A YU64000 A YU 64000A RS 49955 B RS49955 B RS 49955B
Authority
RS
Serbia
Prior art keywords
alginic acid
compositions containing
stable compositions
levosimendan
containing levosimendan
Prior art date
Application number
YUP-640/00A
Other languages
English (en)
Inventor
Maarit Backman
Ilkka Larma
Original Assignee
Orion Corporation,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corporation, filed Critical Orion Corporation,
Publication of YU64000A publication Critical patent/YU64000A/sh
Publication of RS49955B publication Critical patent/RS49955B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Farmaceutska kompozicija, naznačena time, što sadrži levosimendan kao aktivnu komponentu i alginsku kiselinu kao sredstvo za poboljšanje stabilnosti. Prjiava sadrži još 6patentnih zahteva.
YUP-640/00A 1998-04-23 1999-04-23 Stabilne kompozicije koje sadrže levosimendan i alginsku kiselinu RS49955B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI980902A FI980902A7 (fi) 1998-04-23 1998-04-23 Levosimendaanin stabiileja koostumuksia

Publications (2)

Publication Number Publication Date
YU64000A YU64000A (sh) 2002-12-10
RS49955B true RS49955B (sr) 2008-09-29

Family

ID=8551576

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-640/00A RS49955B (sr) 1998-04-23 1999-04-23 Stabilne kompozicije koje sadrže levosimendan i alginsku kiselinu

Country Status (32)

Country Link
US (1) US6531458B1 (sr)
EP (1) EP1079834B1 (sr)
JP (1) JP4475809B2 (sr)
KR (1) KR100590622B1 (sr)
CN (1) CN1165309C (sr)
AT (1) ATE231395T1 (sr)
AU (1) AU756338B2 (sr)
BG (1) BG64766B1 (sr)
BR (1) BR9909867A (sr)
CA (1) CA2329232C (sr)
CZ (1) CZ290911B6 (sr)
DE (1) DE69905034T2 (sr)
DK (1) DK1079834T3 (sr)
EA (1) EA002428B1 (sr)
EE (1) EE04143B1 (sr)
ES (1) ES2191426T3 (sr)
FI (1) FI980902A7 (sr)
GE (1) GEP20032942B (sr)
HR (1) HRP20000703B1 (sr)
HU (1) HUP0105446A3 (sr)
ID (1) ID26650A (sr)
IL (2) IL138950A0 (sr)
MX (1) MXPA00010368A (sr)
NO (1) NO318575B1 (sr)
NZ (1) NZ507455A (sr)
PL (1) PL192274B1 (sr)
PT (1) PT1079834E (sr)
RS (1) RS49955B (sr)
SK (1) SK284600B6 (sr)
TR (1) TR200003101T2 (sr)
WO (1) WO1999055337A1 (sr)
ZA (1) ZA200005630B (sr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI980901A7 (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
FI109659B (fi) * 1999-09-10 2002-09-30 Orion Yhtymae Oyj Levosimendaanin farmaseuttisia liuoksia
FI20010233A0 (fi) * 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
JPWO2002064120A1 (ja) * 2001-02-13 2004-06-10 大正製薬株式会社 内服ゲル製剤
EP1858518A1 (en) * 2005-03-14 2007-11-28 Orion Corporation A combination treatment for enhancing diuresis
HRP20200329T1 (hr) * 2015-11-06 2020-07-24 Carinopharm Gmbh Poboljšane formulacije levosimendana za intravensku primjenu u obliku infuzije ili injekcije i koncentrata infuzije
JP2023507626A (ja) 2019-12-16 2023-02-24 テナックス・セラピューティクス，インコーポレイテッド 駆出率が保たれた心不全を伴う肺高血圧症（ＰＨ－ＨＦ－ｐＥＦ）を治療するためのレボシメンダン

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509866A (en) 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
NZ203684A (en) * 1982-04-05 1986-06-11 Merck Sharp & Dohme Granular formulation for the stabilization of unstable drugs or food supplements
EP0123291A2 (en) 1983-04-20 1984-10-31 Kyowa Hakko Kogyo Co., Ltd. Method for stabilizing interferon
US4906630A (en) * 1985-11-22 1990-03-06 Rorer Pharmaceutical Corporation Method of increasing cardiac contractility using pharmaceutical compositions comprising benzodiazinone- pyridazinone or hydroxy-pyrazolyl compounds
US4716042A (en) * 1986-06-16 1987-12-29 American Home Products Corporation Stabilized coated aspirin tablets
GB8903130D0 (en) 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2251615B (en) 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
GB9614098D0 (en) 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
FI973804A7 (fi) * 1997-09-26 1999-03-27 Orion Yhtymae Oy Levosimendaanin oraalisia koostumuksia

Also Published As

Publication number Publication date
CA2329232C (en) 2007-10-30
FI980902A0 (fi) 1998-04-23
IL138950A0 (en) 2001-11-25
DE69905034T2 (de) 2003-09-04
IL138950A (en) 2006-08-20
MXPA00010368A (es) 2002-07-02
ES2191426T3 (es) 2003-09-01
EA002428B1 (ru) 2002-04-25
DE69905034D1 (de) 2003-02-27
KR100590622B1 (ko) 2006-06-19
AU3524899A (en) 1999-11-16
JP2002512964A (ja) 2002-05-08
CA2329232A1 (en) 1999-11-04
PT1079834E (pt) 2003-04-30
PL343722A1 (en) 2001-09-10
HUP0105446A3 (en) 2002-09-30
YU64000A (sh) 2002-12-10
HK1031998A1 (en) 2001-07-06
NO318575B1 (no) 2005-04-11
EA200001097A1 (ru) 2001-04-23
KR20010072577A (ko) 2001-07-31
SK15552000A3 (sk) 2001-05-10
ID26650A (id) 2001-01-25
TR200003101T2 (tr) 2001-01-22
JP4475809B2 (ja) 2010-06-09
NO20005312D0 (no) 2000-10-20
CZ290911B6 (cs) 2002-11-13
HUP0105446A2 (hu) 2002-07-29
ZA200005630B (en) 2002-01-14
NZ507455A (en) 2002-02-01
EE200000616A (et) 2002-06-17
HRP20000703A2 (en) 2001-04-30
BG104958A (bg) 2001-07-31
SK284600B6 (sk) 2005-07-01
BG64766B1 (bg) 2006-03-31
GEP20032942B (en) 2003-04-25
HRP20000703B1 (hr) 2009-11-30
ATE231395T1 (de) 2003-02-15
PL192274B1 (pl) 2006-09-29
CN1298303A (zh) 2001-06-06
CN1165309C (zh) 2004-09-08
AU756338B2 (en) 2003-01-09
EP1079834B1 (en) 2003-01-22
US6531458B1 (en) 2003-03-11
EE04143B1 (et) 2003-10-15
BR9909867A (pt) 2000-12-19
EP1079834A1 (en) 2001-03-07
FI980902A7 (fi) 1999-10-24
NO20005312L (no) 2000-11-21
DK1079834T3 (da) 2003-04-07
CZ20003779A3 (en) 2001-05-16
WO1999055337A1 (en) 1999-11-04

Similar Documents

Publication Publication Date Title
DE69928938D1 (de) Neues cyclosporin mit verbesserter wirkung
DZ2964A1 (fr) Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
ITRM920361A1 (it) Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo.
IL143673A0 (en) Compositions comprising 1,1,1,3,3-pentaflurobutane and use of said compositions
AU7931301A (en) Method of using diketopiperazines and composition containing them
SE9504661D0 (sv) New compounds
PT1073470E (pt) Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos
BG103590A (en) Pesticide 1-arylpyrazols
ATE460921T1 (de) Medikamenthaltige zusammensetzung in aerosolform
FR2705566B1 (fr) Nouvelles compositions pharmaceutiques.
RS50360B (sr) Farmaceutske formulacije derivata platine
EE04450B1 (et) Farmatseutilised kompositsioonid kahe või enama toimeainega aerosoolidele
HRP20010463B1 (hr) Smjesa s kontroliranim otpuštanjem koja sadrži galantamin
DK1093819T3 (da) Forbindelse og præparat til tilförsel af aktive midler
DK1299348T3 (da) Forbindelser og sammensætninger til levering af aktive midler
BR0212921A (pt) Composição farmacêutica com base em fondant
SE9802729D0 (sv) Novel Compounds
CA2420874A1 (en) Active ingredient combinations with insecticidal and acaricidal properties
RS49723B (sr) Farmaceutska kompozicija koja sadrži entakapon ili nitekapon kao i umreženi derivat celuloze
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
AP2003002716A0 (en) Medicinal compositions containing propenone derivatives.
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
NO20012727L (no) 3,4,5-trisubstituerte arylnitronforbindelser og farmasöytiske sammensetninger som inneholder samme
RS49955B (sr) Stabilne kompozicije koje sadrže levosimendan i alginsku kiselinu
BR0116205A (pt) 2-piridonas antimicrobianas, suas composições e usos